Stockreport

Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results [Yahoo! Finance]

Valneva SE - American Depositary Shares  (VALN) 
PDF Dive Brief: Pfizer and partner Valneva said Monday they plan to seek regulatory approval of their experimental Lyme disease vaccine even though the shot missed its ma [Read more]